Sort
27,075 grants matching “cholesterol”
Lipid functions in bacterial cell organization
$403,825Brittany Jo Belin · Carnegie Institution Of Washington, D.C. · R35 · FY2024 · GM
Lipid functions in bacterial cell organization
$403,825Brittany Jo Belin · Carnegie Institution Of Washington, D.C. · R35 · FY2025 · GM
Regulation of successful optic nerve regeneration by the mevalonate/cholesterol pathway
$403,812Matthew B Veldman · Medical College Of Wisconsin · R01 · FY2022 · EY
ABCA1/G1 and LXRs in Atherogenesis
$403,760Alan Richard Tall · Columbia University Health Sciences · R01 · FY2015 · HL
ABCA1/G1 and LXRs in Atherogenesis
$403,760Alan Richard Tall · Columbia University Health Sciences · R01 · FY2016 · HL
ABCA1/G1 and LXRs in Atherogenesis
$403,760Alan Richard Tall · Columbia University Health Sciences · R01 · FY2017 · HL
ABCA1/G1 and LXRs in Atherogenesis
$403,760Alan Richard Tall · Columbia University Health Sciences · R01 · FY2018 · HL
Membrane Raft Platforms in Inflammasome Activation and Endothelial Dysfunction
$403,758Pin-Lan Li · Virginia Commonwealth University · R01 · FY2015 · HL
Role of Foxa2 in ligand-dependent activation of nuclear receptors
$403,750Irina Bochkis · University Of Virginia · R01 · FY2022 · DK
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability
$403,750Henry J. Pownall · Methodist Hospital Research Institute · R01 · FY2021 · HL
Pannexin 1 channels in diet-induced metabolic syndrome
$403,750Norbert Leitinger · University Of Virginia · P01 · FY2019 · HL
Elucidating a role for Calcium signaling in activation of the Nlrp3 inflammasome
$403,750Tiffany Horng · Harvard School Of Public Health · R01 · FY2016 · AI
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability
$403,750Henry J. Pownall · Methodist Hospital Research Institute · R01 · FY2020 · HL
Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis
$403,750Coleen A McNamara · University Of Virginia · R01 · FY2020 · HL
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability
$403,750Henry J. Pownall · Methodist Hospital Research Institute · R01 · FY2022 · HL
Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis
$403,750Coleen A McNamara · University Of Virginia · R01 · FY2022 · HL
Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis
$403,750Coleen A McNamara · University Of Virginia · R01 · FY2021 · HL
Elucidating a role for Calcium signaling in activation of the Nlrp3 inflammasome
$403,750Tiffany Horng · Harvard School Of Public Health · R01 · FY2015 · AI
Elucidating a role for Calcium signaling in activation of the Nlrp3 inflammasome
$403,750Tiffany Horng · Harvard School Of Public Health · R01 · FY2014 · AI
Non-canonical inflammasome in activation in RPE degeneration
$403,750Jayakrishna Ambati · University Of Virginia · R01 · FY2019 · EY
Role of Foxa2 in ligand-dependent activation of nuclear receptors
$403,750Irina Bochkis · University Of Virginia · R01 · FY2020 · DK
Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis
$403,750Coleen A McNamara · University Of Virginia · R01 · FY2019 · HL
Regulation of Triglyceride Metabolism by the transcription factor CREB-H
$403,750Ann Hwee Lee · Harvard School Of Public Health · R01 · FY2011 · DK
Elucidating a role for Calcium signaling in activation of the Nlrp3 inflammasome
$403,750Tiffany Horng · Harvard School Of Public Health · R01 · FY2017 · AI
Role of Foxa2 in ligand-dependent activation of nuclear receptors
$403,750Irina Bochkis · University Of Virginia · R01 · FY2023 · DK